Pelayo, Jona .
HRN: 19-73-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2022
CEFUROXIME 500MG (TAB)
09/17/2022
09/23/2022
PO
500mg
BID
S/P NSVD With RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes